Eli Lilly Aktie: Orale GLP-1-Konkurrenz schwächelt – Börse Express
The Oral GLP-1 Race: Who Will Win the Weight-Loss War? The pharmaceutical world is in a frenzy. The focus has shifted from injectable weight-loss drugs to oral GLP-1 medications, promising a convenient and potentially game-changing alternative for those struggling with obesity. But who’s leading the pack, and what does this mean for the future of … Read more